Version: 1.0.0 | Published: 8 Oct 2024 | Updated: 229 days ago
Documentation
Description:
The electronic data will consist of documenting the different diagnostic reagents imported, with their technical details, specifications and expiry dates. A record will be kept of the use of these reagents, and their performance characteristics in the research laboratory. The second main data set will involve the development of the diagnostic kits, and documentation of all physical, chemical and immunological parameters around each diagnostic procedure, and the outcomes, and whether success or failure. The third set of data will be generated when the developed diagnostic kits are tested against the known samples received from the commercial (Metropole) laboratories and the results compared.
Coverage
Spatial:
Pakistan
Typical Age Range:
0-150
Pathway:
Human tissue samples collected from patients who attend routine diagnostic
procedures at commercial laboratories and hospitals, especially for COVID
related tests
Provenance
Origin
Sources:
Other
Collection Situations:
Other
Temporal
Accrual Periodicity:
Static
Start Date:
15 August 2021
End Date:
30 November 2021
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
Access Service:
Access is managed on a project-by-project basis. Contact the RESPIRE
Collaboration.
Delivery Lead Time:
Not applicable
Jurisdictions:
PK
Data Controller:
RESPIRE
Data Processor:
RESPIRE
Usage
Data Use Limitations:
No restriction
Resource Creators:
RESPIRE Collaboration
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Languages:
en
Formats:
CSV
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Findings
Observations Not Applicable at this time (Oct 2021) and default values used where fields are mandatory
1
Count
30 November 2021